Posts by:
Over two hundred years since Parkinson’s disease was first described by James Parkinson in 1817, there is still no cure for this incredibly disabling illness. The progressive neurological condition affects about 145,000 people in the UK, with estimates of up to 14 million people worldwide. Not only is there no cure, but the primary treatment, the dopamine-replacement therapy Levodopa, was first developed over 50 years ago.
Saving Lives with Better Detection/ Targeted Research
Awareness of mental health has never been higher. But for those with disorders such as bipolar -estimated to be more than one million people in the UK – the escalated stress levels during the current pandemic crisis is likely to have serious implications.
The cost of hidden, undiagnosed disease is widely recognised and is the focus of this year’s World Kidney Day. It is estimated that while three million people in the UK are affected by chronic kidney disease (CKD), up to one million may be undiagnosed.
The end of February marks the 13th International Rare Disease Day. A day aimed at raising awareness about rare diseases and the impact on patient’s lives.
On World Cancer Day, we wanted to show you how THIN® data can be used to generate insights and enable healthcare research to help improve the lives of patients at risk of and living with cancer.
Cegedim has announced an unparalleled European collaboration with Sanofi, delivering Real World Data to improve health.
